Page last updated: 2024-08-16

ribavirin and Depression, Endogenous

ribavirin has been researched along with Depression, Endogenous in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	16 (64.00)	29.6817
2010's	9 (36.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baranyi, A; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R	1
Feld, JJ; Shah, H; Sheehan, K; Sockalingam, S	1
Bassiony, MM; El-Shabrawi, A; El-Shafeey, M; Fouad, E; Raya, Y; Yousef, A	1
Banjac, V; Miskovic, M; Zivlak-Radulovic, N	1
Białkowska, J; Dworniak, D; Jabłkowski, M; Pawełczyk, A; Pawełczyk, T; Rabe-Jabłońska, J; Strzelecki, D	1
Borisov, AS; Drake, DF; Majer, M; Massung, B; Miller, AH; Pagnoni, G; Raison, CL; Vogt, GJ; Woolwine, BJ	1
Arribas, JR; Fraile, JM; González, JJ; Montes, ML	1
Mauss, S; Schaefer, M	1
Clarke, C; Ferlic-Stark, L; Goodgame, R; Raghavan, R; Rungta, M	1
Fischer, K; Fransen van de Putte, DE; Mauser-Bunschoten, EP; Posthouwer, D	1
de Oliveira, IR; Galvão-de Almeida, A; Guindalini, C; Koenen, KC; Lyra, AC; Miranda-Scippa, A; Paraná, R; Parise, CL; Quarantini, LC; Sampaio, AS	1
Chapman, J; Cheung, R; Hockemeyer, J; Jones, S; Oser, M; Weitlauf, J	1
Delić, D; Jašović-Gašić, M; Marić, NP; Pavlović, Z; Vuković, O	1
Gournay, J; Richou, C	1
Carenzi, S; Ciancio, A; Olivero, A; Rizzetto, M; Saracco, G	1
Asnis, GM; De La Garza, R; Miller, AH; Raison, CL	1
Aspinall, RJ; Pockros, PJ	1
Douglas, SD	1
Borisov, AS; Broadwell, SD; Capuron, L; Jacobson, IM; Manatunga, AK; Miller, AH; Nemeroff, CB; Raison, CL; Woolwine, BJ	1
Borisov, AS; Broadwell, SD; Capuron, L; Jacobson, IM; Miller, AH; Nemeroff, CB; Raison, CL; Woolwine, BJ	1
Dieterich, DT; Gorman, JM; Reichenberg, A	1
Balan, V; Krahn, LE; Martin, KA; Rosati, MJ	1
Ferenci, P; Staufer, K	1
Ahmed, A; Cheung, R	1
Farah, A	1

Reviews

4 review(s) available for ribavirin and Depression, Endogenous

Article	Year
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Current drug abuse reviews, 2008, Volume: 1, Issue:2 Topics: Alcoholism; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Illicit Drugs; Interferon alpha-2; Interferon-alpha; Methadone; Narcotics; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous	2008
[Treatment of chronic hepatitis C: side effects, tolerability and quality of life]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Anemia, Hemolytic; Antiviral Agents; Blood Cell Count; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Neutropenia; Prospective Studies; Quality of Life; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors	2002
Therapy of chronic hepatitis C: a critical review. Current drug targets. Infectious disorders, 2003, Volume: 3, Issue:1 Topics: Age Factors; Alanine Transaminase; Animals; Blood Coagulation Disorders, Inherited; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Pregnancy; Recurrence; Renal Insufficiency; Ribavirin; Treatment Outcome	2003
The management of side-effects during therapy for hepatitis C. Alimentary pharmacology & therapeutics, 2004, Nov-01, Volume: 20, Issue:9 Topics: Antiviral Agents; Depressive Disorder; Drug Carriers; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2004

Trials

3 trial(s) available for ribavirin and Depression, Endogenous

Article	Year
[Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2008, Volume: 24, Issue:144 Topics: Adult; Antiviral Agents; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin	2008
The role of patient religiosity in the evaluation and treatment outcomes for chronic HCV infection. Journal of religion and health, 2013, Volume: 52, Issue:1 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Illness Behavior; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Observational Studies as Topic; Patient Acceptance of Health Care; Patient Satisfaction; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Religion and Medicine; Religion and Psychology; Retrospective Studies; Ribavirin; Sex Factors; Surveys and Questionnaires; Treatment Outcome; Viral Load	2013
Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS (London, England), 2005, Volume: 19 Suppl 3 Topics: Adult; Aged; Antiviral Agents; Cognition Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin	2005

Other Studies

18 other study(ies) available for ribavirin and Depression, Endogenous

Article	Year
Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection. Psychosomatic medicine, 2014, Volume: 76, Issue:3 Topics: Adult; Analysis of Variance; Antiviral Agents; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Depression; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Nitric Oxide Synthase; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Ribavirin; Risk Factors; Time Factors	2014
Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals. The American journal of psychiatry, 2015, Volume: 172, Issue:6 Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Comorbidity; Cooperative Behavior; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interdisciplinary Communication; Interferon alpha-2; Interferon-alpha; Male; Mianserin; Middle Aged; Mirtazapine; Physician's Role; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uridine Monophosphate	2015
Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt. International journal of psychiatry in clinical practice, 2015, Volume: 19, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Anxiety Disorders; Case-Control Studies; Cognition Disorders; Depressive Disorder; Egypt; Female; Hepatitis C; Humans; Interferons; Male; Middle Aged; Prevalence; Prospective Studies; Ribavirin; Risk Factors; Surveys and Questionnaires; Young Adult	2015
The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska. Medical archives (Sarajevo, Bosnia and Herzegovina), 2016, Volume: 70, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Bosnia and Herzegovina; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Personality Inventory; Prospective Studies; Ribavirin; Risk Factors; Severity of Illness Index; Sex Distribution; Young Adult	2016
Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological psychiatry, 2009, Feb-15, Volume: 65, Issue:4 Topics: Adult; Antiviral Agents; Biogenic Monoamines; Biomarkers; Central Nervous System; Corticotropin-Releasing Hormone; Cytokines; Depressive Disorder; Female; Humans; Inflammation; Interferon-alpha; Longitudinal Studies; Male; Neural Pathways; Psychiatric Status Rating Scales; Ribavirin	2009
[Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1 Topics: Adult; Anti-HIV Agents; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Chorea; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Polypharmacy; Recombinant Proteins; Ribavirin; Sensation Disorders; Thyroiditis, Autoimmune; Thyroxine	2009
The burden of HCV treatment in patients with inherited bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia, 2011, Volume: 17, Issue:5 Topics: Adolescent; Adult; Aged; Antiviral Agents; Blood Coagulation Disorders, Inherited; Cost of Illness; Depressive Disorder; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Quality of Life; Ribavirin; Surveys and Questionnaires; Young Adult	2011
Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C. Brain, behavior, and immunity, 2011, Volume: 25, Issue:7 Topics: Adult; Alleles; Antiviral Agents; Brazil; Cross-Sectional Studies; Depression; Depressive Disorder; Female; Genetic Association Studies; Genotype; Hepatitis C; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Ribavirin	2011
Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation. The American journal of gastroenterology, 2011, Volume: 106, Issue:12 Topics: Antiviral Agents; California; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin; Treatment Outcome; Veterans	2011
Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Psychiatria Danubina, 2011, Volume: 23, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Personality Inventory; Psychometrics; Ribavirin; Risk Factors; Young Adult	2011
Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:4 Topics: Antiviral Agents; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Research Design; Ribavirin	2004
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions. Brain, behavior, and immunity, 2005, Volume: 19, Issue:1 Topics: Antiviral Agents; Comorbidity; Depressive Disorder; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Treatment Failure; Viral Load	2005
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain, behavior, and immunity, 2005, Volume: 19, Issue:1 Topics: Adult; Antiviral Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Statistics, Nonparametric; Substance-Related Disorders; Treatment Failure; Treatment Outcome; Viral Load	2005
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1 Topics: Administration, Buccal; Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Depressive Disorder; Dose-Response Relationship, Drug; Drug Carriers; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Personality Inventory; Polyethylene Glycols; Prevalence; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index	2005
Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7 Topics: Adult; Antiviral Agents; Depressive Disorder; Drug Interactions; Female; Hemorrhage; Hepatitis C; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin; Selective Serotonin Reuptake Inhibitors	2007
Depression in chronic hepatitis: the virus, the drug, or the ethnic background? Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:4 Topics: Antiviral Agents; Depressive Disorder; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Interferons; Liver Function Tests; Male; Ribavirin; Risk Assessment; Severity of Illness Index	2008
Treating chronic Hepatitis C patients with psychiatric disorders: an uphill battle. The American journal of gastroenterology, 2001, Volume: 96, Issue:1 Topics: Clinical Trials as Topic; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Prognosis; Ribavirin; Risk Assessment	2001
Interferon-induced depression treated with citalopram. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:2 Topics: Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Middle Aged; Ribavirin; Treatment Outcome	2002